jueves, 12 de junio de 2014

Ahead of Print -Undiagnosed Acute Viral Febrile Illnesses, Sierra Leone - Volume 20, Number 7—July 2014 - Emerging Infectious Disease journal - CDC

full-text ►

Ahead of Print -Undiagnosed Acute Viral Febrile Illnesses, Sierra Leone - Volume 20, Number 7—July 2014 - Emerging Infectious Disease journal - CDC





Volume 20, Number 7—July 2014

Research

Undiagnosed Acute Viral Febrile Illnesses, Sierra Leone

Randal J. SchoeppComments to Author , Cynthia A. Rossi, Sheik H. Khan, Augustine Goba, and Joseph N. Fair
Author affiliations: US Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA (R.J. Schoepp, C.A. Rossi)Kenema Government Hospital, Kenema, Sierra Leone (S.H. Khan, A. Goba)Metabiota, San Francisco, California, USA (J.N. Fair)

Abstract

Sierra Leone in West Africa is in a Lassa fever–hyperendemic region that also includes Guinea and Liberia. Each year, suspected Lassa fever cases result in submission of ≈500–700 samples to the Kenema Government Hospital Lassa Diagnostic Laboratory in eastern Sierra Leone. Generally only 30%–40% of samples tested are positive for Lassa virus (LASV) antigen and/or LASV-specific IgM; thus, 60%–70% of these patients have acute diseases of unknown origin. To investigate what other arthropod-borne and hemorrhagic fever viral diseases might cause serious illness in this region and mimic Lassa fever, we tested patient serum samples that were negative for malaria parasites and LASV. Using IgM-capture ELISAs, we evaluated samples for antibodies to arthropod-borne and other hemorrhagic fever viruses. Approximately 25% of LASV-negative patients had IgM to dengue, West Nile, yellow fever, Rift Valley fever, chikungunya, Ebola, and Marburg viruses but not to Crimean-Congo hemorrhagic fever virus.
The West African country of Sierra Leone is located in a Lassa fever–hyperendemic region that also includes Guinea and Liberia. The causative agent of Lassa fever is Lassa virus (LASV), a member of the Arenaviridae family. Lassa fever is a severe, often fatal, hemorrhagic illness; the virus causes 100,000–300,000 infections and 5,000 deaths each year in the region (1).
Figure
Thumbnail of Lassa fever–hyperendemic region (white area) comprising Guinea, Sierra Leone, and Liberia in West Africa. Insert, upper right: Africa, with West African countries highlighted; lower left: Lassa Diagnostic Laboratory, Kenema Government Hospital, Kenema, Sierra Leone.
Figure. Lassa fever–hyperendemic region (white area) comprising Guinea, Sierra Leone, and Liberia in West AfricaInsert, upper right: Africa, with West African countries highlighted; lower left: Lassa Diagnostic Laboratory, Kenema Government Hospital, Kenema,...
In 2002, Sierra Leone emerged from a brutal 11-year civil war that left the country with little infrastructure and much of its formal economy destroyed. Today Sierra Leone is undergoing substantial economic growth; however, poverty, unemployment, and inadequate health care remain major challenges. Through the Mano River Union–Lassa Fever Network, a variety of organizations are building diagnostic capacity for Lassa fever that will lead to better understanding of the disease and its treatment (25). These scientific efforts are centered in eastern Sierra Leone at the Kenema Government Hospital (Kenema, Sierra Leone) within the Lassa fever–hyperendemic region (Figure). The Lassa Fever Ward, a 16-bed facility on the hospital grounds, is dedicated to treating patients suspected of having Lassa fever and is supported by the Lassa Diagnostic Laboratory.
Each year, suspected Lassa fever infections result in submission of ≈500–700 samples to the Kenema Government Hospital Lassa Diagnostic Laboratory (J. Bangura, unpub. data). Samples come from throughout the Lassa fever–hyperendemic region and initially are screened for malaria by thick blood smear and, if negative, are tested for LASV. LASV infection is determined by the presence of virus detected by an antigen-detection ELISA and by the presence of IgM determined by using an IgM-capture ELISA. Generally only 30%–40% of samples tested are positive for LASV antigen and/or LASV-specific IgM; therefore, 60%–70% of patients have acute diseases of unknown origin. We investigated what other arthropod-borne and hemorrhagic fever viral diseases might be causing serious illness in the region and confounding the diagnosis of Lassa fever. We tested samples from these patients using IgM-capture ELISAs to virus pathogens that could occur in the region and mimic Lassa fever. We tested for IgM to dengue virus (DENV), West Nile virus (WNV), yellow fever virus (YFV), Rift Valley fever virus (RVFV), chikungunya virus (CHIKV), Ebola virus (EBOV), Marburg virus (MBGV), and Crimean-Congo hemorrhagic fever virus (CCHFV). Follow up analyses included IgG ELISAs and/or confirmatory plaque-reduction neutralization tests (PRNTs). This study provides a better understanding of the differential diagnoses for Lassa fever in the region, which can lead to improved diagnostic capability and disease treatment.


Dr Schoepp serves as chief of the Applied Diagnostics Department, Diagnostic Systems Division, US Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA. His research interests include the pathogenesis and ecology of arthropod-borne and hemorrhagic fever viruses in the human host and the animal and/or arthropod reservoir.

Acknowledgments

We thank all the dedicated and hardworking employees of the Kenema Government Hospital. We extend special thanks to Bayon Bockarie, Mohammed Fullah, James J. Bangura, Ashley M. Zovanyi, Tamara E. Clements, Denise K. Danner, Jim F. Barth, Matthew A. Voorhees, and Eric M. Mucker for their expert technical assistance. We also acknowledge Robert F. Garry for his generosity in sharing the valuable clinical samples analyzed in this study.
The laboratory work was funded in part by the Division of Global Emerging Infections Surveillance and Response System Operations at the Armed Forces Health Surveillance Center, Research Plans (C0169_10_RD, C0410_11_RD, and C0602_12_RD), through USAMRIID and by the US Department of Defense Cooperative Biological Engagement Program, through Metabiota, Inc., San Francisco, CA, USA.

References

  1. McCormick JBWebb PAKrebs JWJohnson KMSmith ESA prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis1987;155:43744DOIExternal Web Site IconPubMedExternal Web Site Icon
  2. Hadi CMGoba AKhan SHBangura JSankoh MKoroma SRibavirin for Lassa fever postexposure prophylaxis. Emerg Infect Dis2010;16:200911DOIExternal Web Site IconPubMedExternal Web Site Icon
  3. Branco LMBoisen MLAndersen KGGrove JNMoses LMMuncy IJLassa hemorrhagic fever in a late term pregnancy from northern Sierra Leone with a positive maternal outcome: case report. [Erratum in: Virol J. 2011;8:480. ]Virol J2011;8:404DOIExternal Web Site IconPubMedExternal Web Site Icon
  4. Grove JNBranco LMBoisen MLMuncy IJHenderson LASchieffellin JSCapacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: case report. Virol J2011;8:31427DOIExternal Web Site IconPubMedExternal Web Site Icon
  5. Branco LMGrove JNBoisen MLShaffer JGGoba AFullah MEmerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection. Virol J2011;8:478DOIExternal Web Site IconPubMedExternal Web Site Icon
  6. Sabin ABSchlesinger RWProduction of immunity to dengue with virus modified by propagation in mice. Science1945;101:6402DOIExternal Web Site IconPubMedExternal Web Site Icon
  7. Sabin ABThe dengue group of viruses and its family relationships. Bacteriol Rev.1950;14:22532 .PubMedExternal Web Site Icon
  8. Hammon WMRudnick ASather GEViruses associated with epidemic hemorrhagic fevers of the Philippines and Thailand. Science1960;131:11023DOIExternal Web Site IconPubMedExternal Web Site Icon
  9. Melnick JLPaul JRRiordan JTBarnett VHGoldblum NZabin EIsolation from human sera in Egypt of a virus apparently identical to West Nile virus. Proc Soc Exp Biol Med.1951;77:6615DOIExternal Web Site IconPubMedExternal Web Site Icon
  10. Theiler M. The virus. In: Strode K, editor. Yellow fever. New York: McGraw-Hill; 1951. p. 39–136.
  11. Meegan JMThe Rift Valley fever epizootic in Egypt 1977–78. 1. Description of the epizzotic and virological studies. Trans R Soc Trop Med Hyg1979;73:61823DOIExternal Web Site IconPubMedExternal Web Site Icon
  12. Ksiazek TGRollin PEWilliams AJBressler DSMartin MLSwanepoel RClinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis1999;179(Suppl 1):S17787DOIExternal Web Site IconPubMedExternal Web Site Icon
  13. Smith DHJohnson BKIsaacson MSwanapoel RJohnson KMKilley MMarburg-virus disease in Kenya. Lancet1982;1:81620DOIExternal Web Site IconPubMedExternal Web Site Icon
  14. Causey ORKemp GEMadbouly MHDavid-West TSCongo virus from domestic livestock, African hedgehog, and arthropods in Nigeria. Am J Trop Med Hyg.1970;19:84650 .PubMedExternal Web Site Icon
  15. Auperin DDSasso DRMcCormick JBNucleotide sequence of the glycoprotein gene and intergenic region of the Lassa virus S genome RNA. Virology1986;154:15567DOIExternal Web Site IconPubMedExternal Web Site Icon
  16. Chu YKRossi CLeDuc JWLee HWSchmaljohn CSDalrymple JMSerological relationships among viruses in the Hantavirus genus, family Bunyaviridae. Virology.1994;198:196204DOIExternal Web Site IconPubMedExternal Web Site Icon
  17. Duermeyer WWielaard Fvan der Veen JA new principle for the detection of specific IgM antibodies applied in an ELISA for hepatitis A. J Med Virol1979;4:2532DOIExternal Web Site IconPubMedExternal Web Site Icon
  18. Meegan JMYedloutschnig RJPeleg BAShy JPeters CJWalker JSEnzyme-linked immunosorbent assay for detection of antibodies to Rift Valley fever virus in ovine and bovine sera. Am J Vet Res1987;48:113841 .PubMedExternal Web Site Icon
  19. Rossi CADrabick JJGambel JMSun WLewis TEHenchal EALaboratory diagnosis of acute dengue fever during the United Nations mission in Haiti, 1995–1996. Am J Trop Med Hyg1998;59:2758 .PubMedExternal Web Site Icon
  20. Burke DSRamsburg HHEdelman RPersistence in humans of antibody to subtypes of Venezuelan equine encephalomyelitis (VEE) virus after immunization with attenuated (TC-83) VEE virus vaccine. J Infect Dis1977;136:3549DOIExternal Web Site IconPubMedExternal Web Site Icon
  21. Lanciotti RSRoehrig JTDeubel VSmith JParker MSteele KOrigin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States.Science1999;286:23337DOIExternal Web Site IconPubMedExternal Web Site Icon
  22. Beaty BJCalisher CHShope RE. Arboviruses. In: Lennette EH, Lennette DA, Lennette ET, editors. Diagnostic procedures for viral, rickettsial, and chlamydial infections. Washington (DC): American Public Health Association; 1995. p. 189–212.
  23. Jentes ESRobinson JJohnson BWConde ISakouvougui YIverson JAcute arboviral infections in Guinea, West Africa, 2006. [Erratum in: Am J Trop Med Hyg. 2010;83:1174. ]Am J Trop Med Hyg2010;83:38894DOIExternal Web Site IconPubMedExternal Web Site Icon
  24. McCormick JBKing IJWebb PAJohnson KMO’Sullivan RSmith ESA case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis1987;155:44555DOIExternal Web Site IconPubMedExternal Web Site Icon
  25. Powers AMBrault ACTesh RBWeaver SCRe-emergence of chikungunya and o’nyong-nyong viruses: evidence for distinct geographical lineages and distant evolutionary relationships. J Gen Virol2000;81:4719 .PubMedExternal Web Site Icon
  26. Towner JSSealy TKKhristova MLAlbarino CGConlan SReeder SANewly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog.2008;4:e1000212DOIExternal Web Site IconPubMedExternal Web Site Icon
  27. Tomori OFabiyi AAntibodies against arboviruses in Sierra Leone. Trop Geogr Med.1976;28:23943 .PubMedExternal Web Site Icon
  28. Woodruff AWBowen ETPlatt GSViral infections in travellers from tropical Africa. BMJ.1978;1:9568 and. DOIExternal Web Site IconPubMedExternal Web Site Icon
  29. World Health Organization. Global health partners mobilize to counter yellow fever. Geneva: The Organization; 2007.
  30. Thonnon JFontenille DTall ADiallo MRenaudineau YBaudez BRe-emergence of yellow fever in Senegal in 1995. Am J Trop Med Hyg1998;59:10814 .PubMedExternal Web Site Icon
  31. Posey DLO'Rourke TRoehrig JTLanciotti RSWeinberg MMaloney SO’nyong-nyong fever in West Africa. Am J Trop Med Hyg2005;73:32 .PubMedExternal Web Site Icon
  32. Favier CChalvet-Monfray KSabatier PLancelot RFontenille DDubois MARift Valley fever in West Africa: the role of space in endemicity. Trop Med Int Health.2006;11:187888DOIExternal Web Site IconPubMedExternal Web Site Icon
  33. Fontenille DTraore-Lamizana MDiallo MThonnon JDigoutte JPZeller HGNew vectors of Rift Valley fever in West Africa. Emerg Infect Dis1998;4:28993DOIExternal Web Site IconPubMedExternal Web Site Icon
  34. Faye ODiallo MDiop DBezeid OEBa HNiang MRift Valley fever outbreak with east-central African virus lineage in Mauritania, 2003. Emerg Infect Dis2007;13:101623DOIExternal Web Site IconPubMedExternal Web Site Icon
  35. Gonzalez JPLeGuenno BGuillaud MWilson MLA fatal case of Crimean-Congo haemorrhagic fever in Mauritania: virological and serological evidence suggesting epidemic transmission. Trans R Soc Trop Med Hyg1990;84:5736DOIExternal Web Site IconPubMedExternal Web Site Icon
  36. Le Guenno BFormenty PWyers MGounon PWalker FBoesch CIsolation and partial characterisation of a new strain of Ebola virus. [Erratum in: Lancet. 2006;367:816. ].Lancet1995;345:12714DOIExternal Web Site IconPubMedExternal Web Site Icon

Figure

Tables

Suggested citation for this article: Schoepp RJ, Rossi CA, Khan SH, Goba A, Fair JN. Undiagnosed acute viral febrile illnesses, Sierra Leone. Emerg Infect Dis [Internet]. 2014 Jul [date cited].http://dx.doi.org/10.3201/eid2007.131265External Web Site Icon
DOI: 10.3201/eid2007.131265

No hay comentarios:

Publicar un comentario